BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 27932442)

  • 21. Economic evaluation of Zika Contraception Access Network in Puerto Rico during the 2016-17 Zika virus outbreak.
    Li R; Ellington SR; Galang RR; Grosse SD; Mendoza Z; Hurst S; Vale Y; Lathrop E; Romero L
    Contraception; 2022 Mar; 107():68-73. PubMed ID: 34748752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Zika virus public health crisis and the perpetuation of gender inequality in Brazil.
    Coutinho RZ; Montalvo AV; Weitzman A; Marteleto LJ
    Reprod Health; 2021 Feb; 18(1):40. PubMed ID: 33588891
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-acting reversible contraceptive acceptability and unintended pregnancy among women presenting for short-acting methods: a randomized patient preference trial.
    Hubacher D; Spector H; Monteith C; Chen PL; Hart C
    Am J Obstet Gynecol; 2017 Feb; 216(2):101-109. PubMed ID: 27662799
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative study on the efficacy and acceptability of two contraceptive pills administered by the vaginal route: an international multicenter clinical trial.
    Coutinho EM; de Souza JC; da Silva AR; de Acosta OM; Alvarez F; Brache V; Garza Flores J; Vasquez-Estrada L; Santo R; Bassol S
    Clin Pharmacol Ther; 1993 Jan; 53(1):65-75. PubMed ID: 8422744
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined hormonal versus nonhormonal versus progestin-only contraception in lactation.
    Lopez LM; Grey TW; Stuebe AM; Chen M; Truitt ST; Gallo MF
    Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD003988. PubMed ID: 25793657
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reasons for Brazilian women to switch from different contraceptives to long-acting reversible contraceptives.
    Ferreira JM; Nunes FR; Modesto W; Gonçalves MP; Bahamondes L
    Contraception; 2014 Jan; 89(1):17-21. PubMed ID: 24156884
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-acting hormonal contraceptives for women.
    Garza-Flores J; Hall PE; Perez-Palacios G
    J Steroid Biochem Mol Biol; 1991; 40(4-6):697-704. PubMed ID: 1958567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pearl Index study with levonorgestrel-releasing intravaginal rings: using pharmacokinetic results to investigate treatment compliance as a potential contributor for contraceptive failure.
    Nave R; Höchel J; Mellinger U; Kohnke A; Elliesen J; Schmitz H
    Hum Reprod; 2020 Nov; 35(11):2515-2523. PubMed ID: 32914172
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Final Program Data and Factors Associated With Long-Acting Reversible Contraception Removal: The Zika Contraception Access Network.
    Lathrop E; Hurst S; Mendoza Z; Zapata LB; Cordero P; Powell R; Green C; Moreno N; Jamieson DJ; Romero L
    Obstet Gynecol; 2020 May; 135(5):1095-1103. PubMed ID: 32282596
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-acting reversible contraceptive (LARCs) methods.
    Bahamondes L; Fernandes A; Monteiro I; Bahamondes MV
    Best Pract Res Clin Obstet Gynaecol; 2020 Jul; 66():28-40. PubMed ID: 32014434
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extended use up to 5 years of the etonogestrel-releasing subdermal contraceptive implant: comparison to levonorgestrel-releasing subdermal implant.
    Ali M; Akin A; Bahamondes L; Brache V; Habib N; Landoulsi S; Hubacher D;
    Hum Reprod; 2016 Nov; 31(11):2491-2498. PubMed ID: 27671673
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mifepristone treatment prior to insertion of a levonorgestrel releasing intrauterine system for improved bleeding control - a randomized controlled trial.
    Papaikonomou K; Kopp Kallner H; Söderdahl F; Gemzell-Danielsson K
    Hum Reprod; 2018 Nov; 33(11):2002-2009. PubMed ID: 30295731
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contraception and post abortion services: qualitative analysis of users' perspectives and experiences following Zika epidemic in Honduras.
    Belizan M; Maradiaga E; Roberti J; Casco-Aguilar M; Ortez AF; Avila-Flores JC; González G; Bustillo C; Calderón A; Bock H; Cafferata ML; Tavares AB; Alger J; Ali M
    BMC Womens Health; 2020 Sep; 20(1):199. PubMed ID: 32919474
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Role of Public-Private Partnerships to Increase Access to Contraception in an Emergency Response Setting: The Zika Contraception Access Network Program.
    Romero L; Mendoza ZV; Croft L; Bhakta R; Sidibe T; Bracero N; Malave C; Suarez A; Sanchez L; Cordero D; Lathrop E; Monroe J
    J Womens Health (Larchmt); 2020 Nov; 29(11):1372-1380. PubMed ID: 33196331
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Choice of the levonorgestrel intrauterine device, etonogestrel implant or depot medroxyprogesterone acetate for contraception after aspiration abortion.
    Steinauer JE; Upadhyay UD; Sokoloff A; Harper CC; Diedrich JT; Drey EA
    Contraception; 2015 Dec; 92(6):553-9. PubMed ID: 26093190
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-Acting Reversible Contraception and Condom Use Among Female US High School Students: Implications for Sexually Transmitted Infection Prevention.
    Steiner RJ; Liddon N; Swartzendruber AL; Rasberry CN; Sales JM
    JAMA Pediatr; 2016 May; 170(5):428-34. PubMed ID: 26974492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Strategies to improve adherence and continuation of shorter-term hormonal methods of contraception.
    Mack N; Crawford TJ; Guise JM; Chen M; Grey TW; Feldblum PJ; Stockton LL; Gallo MF
    Cochrane Database Syst Rev; 2019 Apr; 4(4):CD004317. PubMed ID: 31013349
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of contraceptive use in Puerto Rico during the 2016 Zika virus outbreak.
    Ellington SR; Rodriguez RS; Goldberg H; Bertolli J; Simeone RM; Mercado AS; Pazol K; Jamieson DJ; Honein MA; Swartzendruber A; Miles T; Cordero JF; Shapiro-Mendoza CK
    Contraception; 2020 Jun; 101(6):405-411. PubMed ID: 32194040
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.
    Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S
    Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Magnitude and factors for method discontinuation and switching among long acting reversible contraceptive users in health facilities of Southern Ethiopia.
    Bereku T; Habtu Y; Abreham B; Ayele M; Eliso M
    Reprod Health; 2022 Feb; 19(1):47. PubMed ID: 35183214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.